IP Library Granted Patent US 8,148,517
Granted Patent B2
US 8,148,517 · App. 11/909,926 · Granted Apr 3, 2012

Phosphorylated waxy potato starch

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,148,517
App. No.
11/909,926
Granted
Apr 3, 2012
Kind
B2
Abstract

The invention relates to potato starches having an amylose content of less than 10% by weight, a phosphate content in the C6 position of between 35 and 100 nmol of phosphate per milligram of starch and a content of side chains having a DP of from 12 to 19 which is elevated as compared with that in potato starch from corresponding wild-type potato plants.

Claims (114)

1. A potato starch comprising an amylose content as measured by the method of Hovenkamp-Hermelink et al., of less than 10% by weight, a phosphate content in the C6 position of between 35 and 100 nmol of phosphate per milligram of starch (dry weight), and a proportion of side chains having a degree of polymerization (DP) of from 12 to 19 which is increased to 125%-200% as compared with potato starch from corresponding wild-type potato plants.

2. The potato of claim 1 , wherein said phosphate content in the C6 position is between 40 and 85 nmol of phosphate per milligram of starch (dry weight).

3. The potato starch of claim 1 , wherein said phosphate content in the C6 position is between 45 and 70 nmol of phosphate per milligram of starch (dry weight).

4. The potato starch of claim 1 , wherein said phosphate content in the C6 position is between 50 and 65 nmol of phosphate per milligram of starch (dry weight).

5. The potato starch of claim 1 , wherein said amylose content, as measured by the method of Hovenkamp-Hermelink et al. is less than 5% by weight.

6. The potato starch of claim 1 , wherein said amylose content, as measured by the method of Hovenkamp-Hermelink et al., is less than 3% by weight.

7. The potato starch of claim 1 , wherein the proportion of side chains having a DP of from 12 to 19 is increased to 130%-480% as compared with potato starch from corresponding wild-type potato plants.

8. The potato starch of claim 1 , wherein the proportion of side chains having a DP of from 63 to 123 is reduced as compared with potato starch from corresponding wild-type potato plants.

9. The potato starch of claim 8 , wherein the proportion of side chains having a DP of from 63 to 123 is reduced to 50%-95% as compared with potato starch from corresponding wild-type potato plants.

10. The potato starch of claim 1 , wherein said phosphate content in the C6 position is elevated by 415%-520% as compared with that in potato starch from corresponding wild-type plants.

11. A derivatized potato starch comprising the potato starch of claim 1 , wherein the derivatized potato starch is obtainable by subjecting the potato starch to a temperature treatment of 120° C.-140° C. in a dry system.

12. A derivatized potato starch comprising the potato starch of claim 1 , wherein the derivatized potato starch is obtainable by treating the potato starch with acid in an aqueous system at temperatures up to 50° C.

13. A derivatized potato starch comprising the potato starch of claim 1 , wherein the derivatized potato starch is a starch ether, crosslinked starch, oxidized starch, or starch ester.

14. A potato starch comprising an amylose content, as measured by the method of Hovenkamp-Hermelink et al., of less than 10% by weight, a phosphate content in the C6 position is between 35 and 100 nmol of phosphate per milligram of starch (dry weight), a total phosphate content to phosphate content in the C6 position ratio of 1.20-1.50, and a proportion of side chains having a DP of from 12 to 19 which is increased to 125%-200% as compared with that in potato starch from corresponding wild-type potato plants.

15. The potato starch of claim 14 , wherein said phosphate content in the C6 position is between 40 and 85 nmol of phosphate per milligram of starch (dry weight).

16. The potato starch of claim 14 , wherein said phosphate content in the C6 position is between 45 and 70 nmol of phosphate per milligram of starch (dry weight).

17. The potato starch of claim 14 , wherein said amylose content, as measured by the method of Hovenkamp-Hermelink et al., is less than 5% by weight.

18. The potato starch of claim 14 , wherein said amylose content, as measured by the method of Hovenkamp-Hermelink et al. is less than 3% by weight.

19. The potato starch of claim 14 , wherein the proportion of side chains having a DP of from 12 to 19 is increased to 130%-180% as compared with potato starch from corresponding wild-type potato plants.

20. The potato starch of claim 14 , wherein said phosphate content in the C6 position is between 50 and 65 nmol of phosphate per milligram of starch (dry weight).

21. A potato starch isolated from a potato plant cell which exhibits an activity

(a) of one or more SSIII proteins which occur endogenously in the plant cell;

(b) of one or more BEI proteins which occur endogenously in the plant cell;

(c) of one or more GBSSI proteins which occur endogenously in the plant cell; and

(d) of one or more proteins which occur endogenously in the plant cell and which exhibit an at least 90% identity with the amino acid sequence of SEQ ID NO: 12 or SEQ ID NO: 14,

which is reduced as compared with that of corresponding wild-type potato plant cells, and

wherein said starch has a proportion of side chains having a degree of polymerization (DP) of from 12 to 19 which is increased to 125%-200% as compared with potato starch from corresponding wild-type potato plants.

22. The starch of claim 21 , wherein said starch is isolated from a potato plant cell comprising

(a) a first foreign nucleic acid molecule that reduces the expression of at least one endogenous gene encoding a SSIII protein;

(b) a second foreign nucleic acid molecule that reduces the expression of at least one endogenous gene encoding a BEI protein; and

(c) a third foreign nucleic acid molecule that reduces the expression of at least one endogenous gene encoding a GBSSI protein; and

(d) a fourth foreign nucleic acid molecule that reduces the expression of at least one nucleic acid molecule that has an identity of at least 90% with SEQ ID NO: 11 or SEQ ID NO: 13.

23. The starch of claim 22 , wherein

(a) said first foreign nucleic acid molecule is

(i) a nucleic acid molecule, which comprises the nucleotide sequence of SEQ ID NO: 1 or a complementary sequence thereof; or

(ii) a nucleic acid molecule, which has an identity of at least 95% with nucleic acid sequence with SEQ ID NO: 1

(b) said second foreign nucleic acid molecule is

(i) a nucleic acid molecule, which comprises the nucleotide sequence of SEQ ID NO: 4 or a complementary sequence thereof; or

(ii) a nucleic acid molecule, which has an identity of at least 95% with nucleic acid sequence with SEQ ID NO: 4;

(c) said third foreign nucleic acid molecule is

(i) a nucleic acid molecule, which comprises the nucleotide sequence of SEQ ID NO 6 or a complementary sequence thereof; or

(ii) a nucleic acid molecule, which has an identity of at least 95% with nucleic acid sequence with SEQ ID NO: 6; and

(d) said fourth foreign nucleic acid molecule is

(i) a nucleic acid molecule, which comprises the nucleotide sequence of SEQ ID NO: 11 or 13 or a complementary sequence thereof; or

(ii) a nucleic acid molecule, which has an identity of at least 95% with nucleic acid sequence with SEQ ID NO: 11 or 13.

24. The starch of claim 22 , wherein

(a) said first foreign nucleic acid molecule is

(i) a DNA molecule encoding at least one antisense RNA that reduces the expression of at least one endogenous gene encoding a SSIII protein;

(ii) a DNA molecule which, via a co-suppression effect, reduces the expression of at least one endogenous gene encoding a SSIII protein; or

(iii) a DNA molecule that simultaneously encodes at least one antisense RNA and at least one sense RNA, where said antisense RNA and said sense RNA form a double-stranded RNA molecule that reduces the expression of at least one endogenous gene encoding a SSIII protein;

(b) said second foreign nucleic acid molecule is

(i) a DNA molecule encoding at least one antisense RNA that reduces the expression of at least one endogenous gene encoding a BEI protein;

(ii) a DNA molecule which, via a co-suppression effect, reduces the expression of at least one endogenous gene encoding a BEI protein; or

(iii) a DNA molecule that simultaneously encodes at least one antisense RNA and at least one sense RNA, where said antisense RNA and said sense RNA form a double-stranded RNA molecule that reduces the expression of at least one endogenous gene encoding a BEI protein;

(c) said third foreign nucleic acid molecule is

(i) a DNA molecule encoding at least one antisense RNA that reduces the expression of at least one endogenous gene encoding a GBSSI protein;

(ii) a DNA molecule which, via a co-suppression effect, reduces the expression of at least one endogenous gene encoding a GBSSI protein; or

(iii) a DNA molecule that simultaneously encodes at least one antisense RNA and at least one sense RNA, where said antisense RNA and said sense RNA form a double-stranded RNA molecule that reduces the expression of at least one endogenous gene encoding a GBSSI protein; and

(d) said fourth foreign nucleic acid molecule is

(i) a DNA molecule encoding at least one antisense RNA that reduces the expression of at least one endogenous gene encoding SEQ ID NO: 12 or 14;

(ii) a DNA molecule which, via a co-suppression effect, reduces the expression of at least one endogenous gene encoding SEQ ID NO: 12 or 14; or

(iii) a DNA molecule that simultaneously encodes at least one antisense RNA and at least one sense RNA, where said antisense RNA and said sense RNA form a double-stranded RNA molecule that reduces the expression of at least one endogenous gene encoding SEQ ID NO: 12 or 14.

25. The starch of claim 24 , wherein

(a) said first foreign nucleic acid molecule is a DNA molecule encoding at least one antisense RNA that reduces the expression of at least one endogenous gene encoding a SSIII protein;

(b) said second foreign nucleic acid molecule is a DNA molecule encoding at least one antisense RNA that reduces the expression of at least one endogenous gene encoding a BEI protein;

(c) said third foreign nucleic acid molecule is a DNA molecule encoding at least one antisense RNA that reduces the expression of at least one endogenous gene encoding a GBSSI protein; and

(d) said fourth foreign nucleic acid molecule is a DNA molecule that simultaneously encodes at least one antisense RNA and at least one sense RNA, where said antisense RNA and said sense RNA form a double-stranded RNA molecule that reduces the expression of at least one endogenous gene encoding SEQ ID NO: 12 or 14.

26. A method of manufacturing a potato starch comprising extracting starch from a potato plant cell, wherein said plant cell exhibits an activity

(a) of one or more SSIII proteins which occur endogenously in the plant;

(b) of one or more BEI proteins which occur endogenously in the plant;

(c) of one or more GBSSI proteins which occur endogenously in the plant; and

(d) of one or more proteins which occur endogenously in the plant and which exhibit an at least 90% identity with the amino acid sequence of SEQ ID NO: 12 or SEQ ID NO: 14,

which is reduced as compared with that of corresponding wild-type potato plant cells, and

wherein said starch has a proportion of side chains having a degree of polymerization (DP) of from 12 to 19 which is increased to 125%-200% as compared with potato starch from corresponding wild-type potato plants.

27. The method of claim 26 , wherein said plant cell comprises

(a) a first foreign nucleic acid molecule that reduces the expression of at least one endogenous gene encoding a SSIII protein;

(b) a second foreign nucleic acid molecule that reduces the expression of at least one endogenous gene encoding a BEI protein; and

(c) a third foreign nucleic acid molecule that reduces the expression of at least one endogenous gene encoding a GBSSI protein; and

(d) a fourth foreign nucleic acid molecule that reduces the expression of at least one nucleic acid molecule that has an identity of at least 90% with SEQ ID NO: 11 or SEQ ID NO: 13.

28. The method of claim 27 , wherein

(a) said first foreign nucleic acid molecule is

(i) a nucleic acid molecule, which comprises the nucleotide sequence of SEQ ID NO: 1 or a complementary sequence thereof; or

(ii) a nucleic acid molecule, which has an identity of at least 95% with nucleic acid sequence with SEQ ID NO: 1

(b) said second foreign nucleic acid molecule is

(i) a nucleic acid molecule, which comprises the nucleotide sequence of SEQ ID NO: 4 or a complementary sequence thereof; or

(ii) a nucleic acid molecule, which has an identity of at least 95% with nucleic acid sequence with SEQ ID NO: 4;

(c) said third foreign nucleic acid molecule is

(i) a nucleic acid molecule, which comprises the nucleotide sequence of SEQ ID NO 6 or a complementary sequence thereof; or

(ii) a nucleic acid molecule, which has an identity of at least 95% with nucleic acid sequence with SEQ ID NO: 6; and

(d) said fourth foreign nucleic acid molecule is

(i) a nucleic acid molecule, which comprises the nucleotide sequence of SEQ ID NO: 11 or 13 or a complementary sequence thereof; or

(ii) a nucleic acid molecule, which has an identity of at least 95% with nucleic acid sequence with SEQ ID NO: 11 or 13.

29. The method of claim 27 , wherein

(a) said first foreign nucleic acid molecule is

(i) a DNA molecule encoding at least one antisense RNA that reduces the expression of at least one endogenous gene encoding a SSIII protein;

(ii) a DNA molecule which, via a co-suppression effect, reduces the expression of at least one endogenous gene encoding a SSIII protein; or

(iii) a DNA molecule that simultaneously encodes at least one antisense RNA and at least one sense RNA, where said antisense RNA and said sense RNA form a double-stranded RNA molecule that reduces the expression of at least one endogenous gene encoding a SSIII protein;

(b) said second foreign nucleic acid molecule is

(i) a DNA molecule encoding at least one antisense RNA that reduces the expression of at least one endogenous gene encoding a BEI protein;

(ii) a DNA molecule which, via a co-suppression effect, reduces the expression of at least one endogenous gene encoding a BEI protein; or

(iii) a DNA molecule that simultaneously encodes at least one antisense RNA and at least one sense RNA, where said antisense RNA and said sense RNA form a double-stranded RNA molecule that reduces the expression of at least one endogenous gene encoding a BEI protein;

(c) said third foreign nucleic acid molecule is

(i) a DNA molecule encoding at least one antisense RNA that reduces the expression of at least one endogenous gene encoding a GBSSI protein;

(ii) a DNA molecule which, via a co-suppression effect, reduces the expression of at least one endogenous gene encoding a GBSSI protein; or

(iii) a DNA molecule that simultaneously encodes at least one antisense RNA and at least one sense RNA, where said antisense RNA and said sense RNA form a double-stranded RNA molecule that reduces the expression of at least one endogenous gene encoding a GBSSI protein; and

(d) said fourth foreign nucleic acid molecule is

(i) a DNA molecule encoding at least one antisense RNA that reduces the expression of at least one endogenous gene encoding SEQ ID NO: 12 or 14;

(ii) a DNA molecule which, via a co-suppression effect, reduces the expression of at least one endogenous gene encoding SEQ ID NO: 12 or 14; or

(iii) a DNA molecule that simultaneously encodes at least one antisense RNA and at least one sense RNA, where said antisense RNA and said sense RNA form a double-stranded RNA molecule that reduces the expression of at least one endogenous gene encoding SEQ ID NO: 12 or 14.

30. The method of claim 29 , wherein

(a) said first foreign nucleic acid molecule is a DNA molecule encoding at least one antisense RNA that reduces the expression of at least one endogenous gene encoding a SSIII protein;

(b) said second foreign nucleic acid molecule is a DNA molecule encoding at least one antisense RNA that reduces the expression of at least one endogenous gene encoding a BEI protein;

(c) said third foreign nucleic acid molecule is a DNA molecule encoding at least one antisense RNA that reduces the expression of at least one endogenous gene encoding a GBSSI protein; and

(d) said fourth foreign nucleic acid molecule is a DNA molecule that simultaneously encodes at least one antisense RNA and at least one sense RNA, where said antisense RNA and said sense RNA form a double-stranded RNA molecule that reduces the expression of at least one endogenous gene encoding SEQ ID NO: 12 or 14.

Assignments (4)
NUNC PRO TUNC ASSIGNMENT Recorded Jul 4, 2023
From: BAYER INTELLECTUAL PROPERTY GMBH
To: BAYER CROPSCIENCE AKTIENGESELLSCHAFT
Reel/Frame 064198/0823 →
CHANGE OF ADDRESS Recorded Jun 12, 2023
From: BAYER INTELLECTUAL PROPERTY GMBH
To: BAYER INTELLECTUAL PROPERTY GMBH
Reel/Frame 064021/0344 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 2, 2015
From: BAYER CROPSCIENCE AG
To: BAYER INTELLECTUAL PROPERTY GMBH
Reel/Frame 035355/0836 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 4, 2007
From: SOYKA, STEPHAN; PILLING, JENS; FROHBERG, CLAUS
To: BAYER CROPSCIENCE AG
Reel/Frame 020190/0564 →